Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. Idoven’s AI-powered platform, WillemTM, delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation and prediction. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious Horizon 2020 (H2020), the European Innovation Council (EIC) Accelerator award from the European Commission and Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Accel Starter programme, Wayra (Telefónica), leading business angels and EIT Health. For more information on Idoven, visit idoven.ai or follow us on LinkedIn @idoven.